These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 38601163)
61. A novel zinc metabolism-related gene signature to predict prognosis and immunotherapy response in lung adenocarcinoma. Chang W; Li H; Ou W; Wang SY Front Immunol; 2023; 14():1147528. PubMed ID: 37033934 [TBL] [Abstract][Full Text] [Related]
62. Construction and validation of a prognostic model for lung adenocarcinoma based on endoplasmic reticulum stress-related genes. Li F; Niu Y; Zhao W; Yan C; Qi Y Sci Rep; 2022 Nov; 12(1):19857. PubMed ID: 36400857 [TBL] [Abstract][Full Text] [Related]
63. A Machine-Learning Approach to Developing a Predictive Signature Based on Transcriptome Profiling of Ground-Glass Opacities for Accurate Classification and Exploring the Immune Microenvironment of Early-Stage LUAD. Zhao Z; Yin W; Peng X; Cai Q; He B; Shi S; Peng W; Tu G; Li Y; Li D; Tao Y; Peng M; Wang X; Yu F Front Immunol; 2022; 13():872387. PubMed ID: 35693786 [TBL] [Abstract][Full Text] [Related]
64. Combining autophagy and immune characterizations to predict prognosis and therapeutic response in lung adenocarcinoma. Li Q; Xie D; Yao L; Qiu H; You P; Deng J; Li C; Zhan W; Weng M; Wu S; Li F; Zhou Y; Zeng F; Zheng Y; Zhou H Front Immunol; 2022; 13():944378. PubMed ID: 36177001 [TBL] [Abstract][Full Text] [Related]
65. Multi-omics identification of GPCR gene features in lung adenocarcinoma based on multiple machine learning combinations. Xie Y; Pan X; Wang Z; Ma H; Xu W; Huang H; Zhang J; Wang X; Lian C J Cancer; 2024; 15(3):776-795. PubMed ID: 38213730 [No Abstract] [Full Text] [Related]
66. Prognostic value and immune infiltration of a novel stromal/immune score-related P2RY12 in lung adenocarcinoma microenvironment. Yu L; Cao S; Li J; Han B; Zhong H; Zhong R Int Immunopharmacol; 2021 Sep; 98():107734. PubMed ID: 34175738 [TBL] [Abstract][Full Text] [Related]
67. Single-cell sequencing analysis and transcriptome analysis constructed the macrophage related gene-related signature in lung adenocarcinoma and verified by an independent cohort. Li R; Tong R; Zhang Z; Deng M; Wang T; Hou G Genomics; 2022 Nov; 114(6):110520. PubMed ID: 36372305 [TBL] [Abstract][Full Text] [Related]
68. Identification of an Amino Acid Metabolism-Related Gene Signature for Predicting Prognosis in Lung Adenocarcinoma. Chang W; Li H; Wu C; Zhong L; Zhu T; Chang Z; Ou W; Wang S Genes (Basel); 2022 Dec; 13(12):. PubMed ID: 36553562 [TBL] [Abstract][Full Text] [Related]
69. A ferroptosis-related gene signature predicts overall survival in patients with lung adenocarcinoma. Gao X; Tang M; Tian S; Li J; Liu W Future Oncol; 2021 Apr; 17(12):1533-1544. PubMed ID: 33432837 [TBL] [Abstract][Full Text] [Related]
70. Molecular map of disulfidptosis-related genes in lung adenocarcinoma: the perspective toward immune microenvironment and prognosis. Zhao F; Su L; Wang X; Luan J; Zhang X; Li Y; Li S; Hu L Clin Epigenetics; 2024 Feb; 16(1):26. PubMed ID: 38342890 [TBL] [Abstract][Full Text] [Related]
71. A Novel Mitochondrial-Related Gene Signature for the Tumor Immune Microenvironment Evaluation and Prognosis Prediction in Lung Adenocarcinoma. Li YP; Liu GX; Wu ZL; Tu PH; Wei G; Yuan M; Zhong MH; Deng KL J Immunol Res; 2022; 2022():5366185. PubMed ID: 35664356 [TBL] [Abstract][Full Text] [Related]
72. Cathepsin B is a potential therapeutic target for coronavirus disease 2019 patients with lung adenocarcinoma. Ding X; Ye N; Qiu M; Guo H; Li J; Zhou X; Yang M; Xi J; Liang Y; Gong Y; Li J Chem Biol Interact; 2022 Feb; 353():109796. PubMed ID: 35007526 [TBL] [Abstract][Full Text] [Related]
73. Development and validation of an immune-related prognostic signature in lung adenocarcinoma. Sun S; Guo W; Wang Z; Wang X; Zhang G; Zhang H; Li R; Gao Y; Qiu B; Tan F; Gao Y; Xue Q; Gao S; He J Cancer Med; 2020 Aug; 9(16):5960-5975. PubMed ID: 32592319 [TBL] [Abstract][Full Text] [Related]
74. LATPS, a novel prognostic signature based on tumor microenvironment of lung adenocarcinoma to better predict survival and immunotherapy response. Huang J; Yuan L; Huang W; Liao L; Zhu X; Wang X; Li J; Liang W; Wu Y; Liu X; Yu D; Zheng Y; Guan J; Zhan Y; Liu L Front Immunol; 2022; 13():1064874. PubMed ID: 36505456 [TBL] [Abstract][Full Text] [Related]
75. Identification and verification of microtubule associated genes in lung adenocarcinoma. Wei Y; Yang C; Wei J; Li W; Qin Y; Liu G Sci Rep; 2023 Sep; 13(1):16134. PubMed ID: 37752167 [TBL] [Abstract][Full Text] [Related]
76. Immune Cell Infiltration and Clinical Significance of Angiogenesis-related Genes in Lung Adenocarcinoma. Zhao QI; Ren W; Gao S; Mu N Anticancer Res; 2023 Oct; 43(10):4473-4489. PubMed ID: 37772547 [TBL] [Abstract][Full Text] [Related]
77. Predicting lung adenocarcinoma prognosis, immune escape, and pharmacomic profile from arginine and proline-related genes. Wang Z; Zhang J; Shi S; Ma H; Wang D; Zuo C; Zhang Q; Lian C Sci Rep; 2023 Sep; 13(1):15198. PubMed ID: 37709932 [TBL] [Abstract][Full Text] [Related]
78. Gene signature based on B cell predicts clinical outcome of radiotherapy and immunotherapy for patients with lung adenocarcinoma. Han L; Shi H; Luo Y; Sun W; Li S; Zhang N; Jiang X; Gong Y; Xie C Cancer Med; 2020 Dec; 9(24):9581-9594. PubMed ID: 33098370 [TBL] [Abstract][Full Text] [Related]
79. Microenvironment Analysis of Prognosis and Molecular Signature of Immune-Related Genes in Lung Adenocarcinoma. Ling B; Huang Z; Huang S; Qian L; Li G; Tang Q Oncol Res; 2021 Mar; 28(6):561-578. PubMed ID: 32471520 [TBL] [Abstract][Full Text] [Related]
80. A novel iTreg-related signature for prognostic prediction in lung adenocarcinoma. Zhang J; Li Y; Yang Y; Huang J; Sun Y; Zhang X; Kong X Cancer Sci; 2024 Jan; 115(1):109-124. PubMed ID: 38015097 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]